INSM

Insmed Incorporated

Price

$126.90

return (12m)

-11.57%

p/e

-24.87

p/bv

34.11

DIVIDEND YIELD

0.00%

INSM price

Insmed

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment INSM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

26.63%

3 months

34.68%

1 year

-11.57%

2 years

73.11%

5 years

350.94%

10 years

826.92%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals INSM

Valuation

P/E

-24.87

Sector -4.23

Industry -4.23

P/BV

34.11

Sector 2.11

Industry 2.11

P/Revenue (PSR)

22.71

Sector 2.05

Industry 2.05

EV/EBITDA

Sector -546.75

Industry -546.75

EV/EBIT

Sector -37.85

Industry -37.85

P/EBITDA

-30.44

Sector -51.33

Industry -51.33

P/EBIT

-29.58

Sector -39.56

Industry -39.56

P/Total Assets

12.29

Sector 1.25

Industry 1.25

P/Net Current Assets

89.46

Sector -5.36

Industry -5.36

P/Working Capital

21.62

Sector -1.24

Industry -1.24

EPS

-4.78

Sector -1.92

Industry -1.92

BVPS

3.49

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

83.27%

Sector 39.10%

Industry 39.10%

EBITDA Margin

2.09%

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

-0.32%

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

-71.86%

Sector -36.62%

Industry -36.62%

Net Profit Margins

-91.32%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.20

Sector 0.03

Industry 0.03

Profitability

ROE

-137.15%

Sector -60.49%

Industry -60.49%

ROA

-49.41%

Sector -63.06%

Industry -63.06%

ROIC

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.72

Sector 2.90

Industry 2.90

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

Sector -0.83

Industry -0.83

Equity/Assets

0.36

Sector 0.43

Industry 0.43

Liabilities/Assets

0.64

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

43.27%

Sector -

Industry -

5Y Earnings CAGR

19.04%

Sector -

Industry -

Fundamentals INSM

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
INSM Insmed Incorporated	$126.90	-11.57%	0.00%	-24.87	34.11	-137.15%	-91.32%
JNJ Johnson & Johnson	$276.47	60.00%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.64	23.67%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$257.20	25.27%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.74	-12.60%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$150.67	85.97%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$162.57	1.81%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.95	47.63%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.67	-49.40%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$438.54	60.04%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$834.48	47.70%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.01	47.03%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$917.36	33.47%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$551.38	39.02%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.79	66.68%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.15	12.31%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,038.19	43.79%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

INSM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Insmed

Insmed Incorporated

Average Investor10 user rating

4.0 (12 people)

United States

27 years

Founded: 1999

2000

Time since IPO - 26 years

521

Employees

Insmed Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $25.84 billion, with shareholders equity totaling $757.49 million.

The company employs approximately 521 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Insmed Incorporated reported $1.14 billion in revenue, generating net income of $-1.04 billion.

Key financial metrics include a P/E ratio of -24.87, a price-to-book (P/B) ratio of 34.11, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker INSM.

Market cap

$25.84 billion

Net worth

$757.49 million

$757,494,000.00

Assets

$2.10 billion

$2,102,565,000.00

Total Shares Outstanding

217.35 million

217,352,000

Average Daily Trading Volume

$4.12 million

$4,122,160.00

Sector

Health Care

Industry

Biotechnology

INSM

revenue by Business Segment Insmed

Revenue by Region Insmed

INSM revenue and profits

Financial Results INSM

DRAG THE FRAME TO SEE MORE DATA

INSM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$917.36 33,35% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.79 68,04% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$276.47 59,32% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$257.20 24,60% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$150.67 86,25% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$162.57 1,91% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.64 24,93% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$917.36 33,35% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.79 68,04% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$276.47 59,32% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$257.20 24,60% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$150.67 86,25% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$162.57 1,91% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.64 24,93% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Insmed (INSM) today?

A cotação de Insmed (INSM) hoje está em US$ 126.90, com uma variação de -11.57% em relação ao último ano. A cotação de Insmed (INSM) iniciou o ano negociando na casa dos US$ 174.04 e hoje está em US$ 126.90. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Insmed (INSM) e dados de ações do Ibovespa e mercados internacionais.

Quando Insmed (INSM) paga dividendos?

Insmed (INSM) não distribuiu dividendos no último ano.

Is Insmed (INSM) a good investment?

Atualmente, Insmed (INSM) está cotada a US$ 126.90, com um P/L de -24.87, representando um desvio de -1,656% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -11.57 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -11.57%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Insmed (INSM) stock?

Investir em ações de Insmed (INSM) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Insmed (INSM) yield today?

A rentabilidade de Insmed (INSM) foi de 26.63% no último mês, -11.57% no último ano e 350.94% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Insmed (INSM) hoje, o investimento total seria de US$ 12,689.50, com base na cotação atual de US$ 126.90.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 11,221.32
Em 5 anos: US$ 57,222.03
Em 10 anos: US$ 117,621.51

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

INSM

Insmed Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment INSM

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING INSM WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Insmed

Insmed Incorporated

United States

27 years

2000

521

PROFIT X PRICE INSM

Financial Results INSM

INSM cash flow

Asset, Revenue and Profit Growth - INSM

INSM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions